These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 10091585)

  • 21. Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin.
    Segers K; Dahlbäck B; Rosing J; Nicolaes GA
    J Biol Chem; 2008 Aug; 283(33):22573-81. PubMed ID: 18519572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.
    Li X; Song X; Mahmood DFD; Sim MMS; Bidarian SJ; Wood JP
    Thromb Res; 2023 Oct; 230():84-93. PubMed ID: 37660436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor V and thrombotic disease: description of a janus-faced protein.
    Nicolaes GA; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):530-8. PubMed ID: 11950687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V.
    Heeb MJ; Kojima Y; Greengard JS; Griffin JH
    Blood; 1995 Jun; 85(12):3405-11. PubMed ID: 7780127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The autolysis loop of activated protein C interacts with factor Va and differentiates between the Arg506 and Arg306 cleavage sites.
    Gale AJ; Heeb MJ; Griffin JH
    Blood; 2000 Jul; 96(2):585-93. PubMed ID: 10887122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C.
    Noordermeer T; Chemlal S; Jansma JJ; van der Vegte V; Schutgens REG; Limper M; de Groot PG; Meijers JCM; Urbanus RT
    J Thromb Haemost; 2023 Sep; 21(9):2509-2518. PubMed ID: 37290588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling of human factor Va inactivation by activated protein C.
    Bravo MC; Orfeo T; Mann KG; Everse SJ
    BMC Syst Biol; 2012 May; 6():45. PubMed ID: 22607732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amino acid region 1000-1008 of factor V is a dynamic regulator for the emergence of procoagulant activity.
    Wiencek JR; Na M; Hirbawi J; Kalafatis M
    J Biol Chem; 2013 Dec; 288(52):37026-38. PubMed ID: 24178294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
    Rosing J; Hoekema L; Nicolaes GA; Thomassen MC; Hemker HC; Varadi K; Schwarz HP; Tans G
    J Biol Chem; 1995 Nov; 270(46):27852-8. PubMed ID: 7499257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining the factor Xa-binding site on factor Va by site-directed glycosylation.
    Steen M; Villoutreix BO; Norstrøm EA; Yamazaki T; Dahlbäck B
    J Biol Chem; 2002 Dec; 277(51):50022-9. PubMed ID: 12384508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance assay.
    Kalafatis M; Haley PE; Lu D; Bertina RM; Long GL; Mann KG
    Blood; 1996 Jun; 87(11):4695-707. PubMed ID: 8639839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated protein C resistance: molecular mechanisms.
    Griffin JH; Heeb MJ; Kojima Y; Fernández JA; Kojima K; Hackeng TM; Greengard JS
    Thromb Haemost; 1995 Jul; 74(1):444-8. PubMed ID: 8578503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor Va-factor Xa interactions: molecular sites involved in enzyme:cofactor assembly.
    Steen M
    Scand J Clin Lab Invest Suppl; 2002; 237():5-11. PubMed ID: 12570161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of factor V by the anticoagulant protease activated protein C: Influence of the B-domain and TFPIα.
    Ayombil F; Petrillo T; Kim H; Camire RM
    J Biol Chem; 2022 Nov; 298(11):102558. PubMed ID: 36183835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional characterization of recombinant FV Hong Kong and FV Cambridge.
    Norstrøm E; Thorelli E; Dahlbäck B
    Blood; 2002 Jul; 100(2):524-30. PubMed ID: 12091344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mechanism of inactivation of human factor V and human factor Va by activated protein C.
    Kalafatis M; Rand MD; Mann KG
    J Biol Chem; 1994 Dec; 269(50):31869-80. PubMed ID: 7989361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cleavage at both Arg306 and Arg506 is required and sufficient for timely and efficient inactivation of factor Va by activated protein C.
    Barhoover MA; Kalafatis M
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):317-24. PubMed ID: 21467919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Dual Regulatory Role of Amino Acids Leu480 and Gln481 of Prothrombin.
    Wiencek JR; Hirbawi J; Yee VC; Kalafatis M
    J Biol Chem; 2016 Jan; 291(4):1565-1581. PubMed ID: 26601957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
    Huang X; Swanson R; Kroh HK; Bock PE
    J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
    Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
    Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.